pipette
ESEspañol

AI-driven discovery and engineering of human-derived protein scaffolds for mRNA delivery

Dongmin Xun, Lanqing Li, Jie Zou, Yi Liu, Ziyue Yang, Qianyi Liang, Ke Li, Zhu Zhu, Jicong Zhang, Lijun Lang, Kun Liu, Xinyu Wang, Meilin Tian, Guangyong Chen, Bolin An, Bolin An, Pheng‐Ann Heng, Chao Zhong

Peer-reviewed journalBold claims, read criticallyReal-world use

In the authors' words

Abstract Safe and effective gene delivery remains a central challenge for therapeutic applications. While non-viral and viral vectors have enabled substantial progress, their reliance on non-human components often triggers immune responses, limiting their use in chronic treatments. Here, we developed DeepDelivery, an artificial intelligence-driven platform to repurpose human proteins for mRNA delivery. An unbiased screening of the human proteome nominated 512 candidates, with experimental validation confirming that 80% of top-ranked hits form mRNA-encapsulating particles and mediate efficient functional delivery in human cells without provoking detectable inflammation. Notably, multiple tripartite motif (TRIM) family proteins, typically linked to antiviral responses, exhibited strong assembly and delivery activity. Quantitative analysis and interpretation of the model revealed structural domains that govern nanocage formation, enabling domain-guided engineering of TRIM25 variants with enhanced function. Our work establishes a generalizable framework for discovering human-derived delivery vehicles and provides a path toward programmable, non-immunogenic mRNA therapeutics.

Main resultThe abstract does not state a limitation.

Appeared: Monday, November 2. Nature Communications. Peer-reviewed journal.

DOI: 10.1038/s41467-026-79039-x